0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessA detailed clinical assessment before starting carfilzomib treatment is essential to identify patients at risk for CVAEs, and accurate monitoring of blood pressure and of early signs and symptoms suggestive of cardiac dysfunction remains pivotal to safely administer carfilzomib without treatment interruptions or dose reductions.
Sara Bringhen, Alberto Milan, Mattia D’Agostino, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Massimo Offidani, Sonja Zweegman, Evangelos Terpos, Hartmut Goldschmidt, Michèle Cavo, H. Ludwig, Christoph Driessen, Holger W. Auner, Jo Caers, Martin Gramatzki, Meletios A Dimopoulos, Mario Boccadoro, H. Einsele, Pieter Sonneveld, Monika Engelhardt (2019). Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. , 286(1), DOI: https://doi.org/10.1111/joim.12882.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2019
Authors
22
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1111/joim.12882
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
